News of the index components BEL-20

Index

BEL20

BE0389555039

Real-time Euronext Bruxelles 05:47:00 2024-05-03 am EDT			5-day change	1st Jan Change
3,925 ^PTS	+0.81%		+1.72%	+5.84%

Apr. 15	Solvay: Deutsche Bank's assessment that the company is well valued causes the share price to fall.	CF
Apr. 04	UCB: new indication in sight for Bimzelx in the USA	CF

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Groupe Bruxelles Lambert : GBL - Transactions on GBL shares 08-04-2024 GBLB	Apr. 08	PU
AB INBEV : RBC reiterates its Buy rating ABI	Apr. 08	ZD
Galapagos Showcases Innovative Approach in Hematological Cancer Care with Clinical and Translational Data Presentations at EBMT Congress 2024 GLPG	Apr. 08	CI
AB INBEV : Deutsche Bank reiterates its Neutral rating ABI	Apr. 08	ZD
Budweiser Brewing Co. APAC Shares Fall on Worries Over 1Q Results ABI	Apr. 08	DJ
KBC Group: Notification for bondholders of KBC IFIMA KBC	Apr. 08	GL
Melexis N : Invitation to the ordinary shareholders' meeting 2024 MELE	Apr. 07	PU
Melexis N : Proxy to the ordinary shareholders' meeting 2024 MELE	Apr. 07	PU
UCB : Acquisition of own shares - 2024 UCB	Apr. 06	PU
Deutsche Bank Raises Solvay PT, Affirms Buy Rating SOLB	Apr. 05	MT
Syensqo joins the EuropaBio association SYENS	Apr. 05	CF
Elia / : joins forces with industry to facilitate smart charging for cars ELI	Apr. 05	PU
SOLVAY : Deutsche Bank raises its target slightly SOLB	Apr. 05	CF
AB INBEV : Buy rating from Jefferies ABI	Apr. 05	ZD
Galapagos : Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 GLPG	Apr. 05	PU
Cofinimmo : Preparation of the extraordinary and ordinary general meetings of 08.05.2024 COFB	Apr. 05	PU
The True Worth of Ageas Shares Ahead of Shareholders' Meeting AGS	Apr. 05	AQ
AB INBEV : UBS reiterates its Neutral rating ABI	Apr. 04	ZD
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 GLPG	Apr. 04	GL
UCB: new indication in sight for Bimzelx in the USA UCB	Apr. 04	CF
Influential investor David Einhorn talks Solvay stock price higher SOLB	Apr. 04	AQ
UCB Announces FDA Accepts Supplemental Biologics License Applications for Bimzelx UCB	Apr. 04	CI
AB InBev prices USD2.5 billion bond repurchase offers ABI	Apr. 04	AN
Sofina : General instructions Lumi Connect SOF	Apr. 04	PU
Sofina : Convening Notice – 4/04/2024 SOF	Apr. 04	PU
Aedifica NV/SA: 2023 Annual Report AED	Apr. 04	GL
UCB : FDA Accepts Supplemental Biologics License Applications for BIMZELX (bimekizumab-bkzx) for Moderate to Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations UCB	Apr. 04	PU
Special report of the Board of Directors – art. 7:199 - 04/04/2024 AED	Apr. 04	PU
Aedifica : Draft amendment Coordinated Articles of Association - 04/04/2024 AED	Apr. 04	PU
AB InBev Prices $2.5 Billion Offer to Redeem Outstanding Euro-denominated Notes ABI	Apr. 04	MT
Aedifica NV/SA: Convocation to the Extraordinary General Meeting and Ordinary General Meeting of 14 May 2024 AED	Apr. 04	GL
Aedifica : Curriculum vitae Elisabeth May-Roberti - 04/04/2024 AED	Apr. 04	PU
Aedifica : Curriculum vitae Kari Pitkin - 04/04/2024 AED	Apr. 04	PU
Aedifica : Convocation & agenda - 04/04/2024 AED	Apr. 04	PU
Aedifica : Curriculum vitae Serge Wibaut - 04/04/2024 AED	Apr. 04	PU
Aedifica : Curriculum vitae Stefaan Gielens - 04/04/2024 AED	Apr. 04	PU
Aedifica : Curriculum vitae Katrien Kesteloot - 04/04/2024 AED	Apr. 04	PU
D'Ieteren : Repurchase and disposal of own shares DIE	Apr. 03	PU
Umicore : Navigating the peaks and troughs for long-term growth UMI	Apr. 03	PU
AB InBev raises bond buyback offers up to USD2.5 billion ABI	Apr. 03	AN